BIOA
Drug Manufacturers - Specialty & Generic · Healthcare
CEO
Equibles does not estimate personal net worth.
Get an email with a short summary when BioAge Labs, Inc. publishes a filing, an earnings call transcript or a press release.
Get BIOA alertsKristen Fortney is recorded as CEO at BioAge Labs, Inc. (BIOA). The newest filing on record that lists Kristen Fortney as CEO at BioAge Labs, Inc. (BIOA) is dated April 21, 2026. The proxy statement of BioAge Labs, Inc. reports total compensation of $2,886,590 for Kristen Fortney in fiscal 2025, including a base salary of $600,000. Disclosed compensation is on record for 3 fiscal years. Kristen Fortney has spoken on 1 earnings call and 3 other investor events across 1 company, most recently for BioAge Labs, Inc. on November 10, 2026. BioAge Labs, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at BioAge Labs, Inc. includes Dov Goldstein (CFO) and Eric Morgen (COO).
“And thanks, Seamus, for having me here today. We're pleased to be here. Looking forward to the conference.”
“No, as you said, it's been a super eventful year for us and for the target. So, you know, when the year started in January, we were in the middle of our phase one.”
“So we are a clinical stage biotech company, and we are applying human aging biology as a lens for target discovery and development of therapies for cardiometabolic disease.”
“We're very excited to share our phase one results for BGE 102 today. We believe these data, showing profound HSCRP reductions with a well-tolerated once-daily oral dose, positioned BGE-102 as a potential best-in-class NLRP3 inhibitor, and they've given us strong conviction to really accelerate the program.”
Start not stated–present
Last confirmed April 21, 2026
BIOA
Drug Manufacturers - Specialty & Generic · Healthcare
CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | BioAge Labs, Inc. (BIOA) | Chief Executive Officer and President | $600,000 | $2,886,590 |
| 2024 | BioAge Labs, Inc. (BIOA) | Chief Executive Officer and President | $520,994 | $12,226,906 |
| 2023 | BioAge Labs, Inc. (BIOA) | Chief Executive Officer and President | $493,271 | $1,380,475 |